Simple agreements for future equity (Details Narrative) - Exascale Labs Inc. [Member] - USD ($) |
9 Months Ended | 11 Months Ended | 12 Months Ended | 33 Months Ended | 42 Months Ended | ||
|---|---|---|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Jun. 06, 2025 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Mar. 31, 2026 |
|
| Aggregate gross proceeds | $ 3,500,000 | $ 4,275,000 | $ 4,307,500 | $ 5,685,000 | $ 10,592,500 | $ 14,092,500 | |
| Equity Financing description | SAFEs with an aggregate purchase amount of $13,632,500 include an Equity Financing conversion feature, while SAFEs with an aggregate purchase amount of $460,000 do not include this feature and are generally settled only upon a Liquidity Event or a Dissolution Event, in accordance with their terms. | SAFEs with an aggregate purchase amount of $10,132,500 include an Equity Financing conversion feature, while SAFEs with an aggregate purchase amount of $460,000 do not include this feature and are generally settled only upon a Liquidity Event or a Dissolution Event, in accordance with their terms. | |||||
| Subsequent Event [Member] | |||||||
| Additional SAFEs proceeds | $ 500,000 | ||||||
| Cumulative proceeds | $ 11,092,500 | ||||||